Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	inclusion criteria: * aged over 16 years old with all genders * sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) * patient or immediate adult family member agrees to participate in this study and signs an informed consent form * asymptomatic or patients with mild covid-19 symptoms * confirmed sars-cov-2 infection within 5 days prior to randomization	inclusion criteria: * aged over 16 years old with all genders * sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) * patient or immediate adult family member agrees to participate in this study and signs an informed consent form * asymptomatic or patients with mild covid-19 symptoms * confirmed sars-cov-2 infection within 5 days prior to randomization
July 16, 2022, 3 a.m.	usa	inclusion criteria: aged over 16 years old with all genders sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) patient or immediate adult family member agrees to participate in this study and signs an informed consent form asymptomatic or patients with mild covid-19 symptoms confirmed sars-cov-2 infection within 5 days prior to randomization	inclusion criteria: aged over 16 years old with all genders sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) patient or immediate adult family member agrees to participate in this study and signs an informed consent form asymptomatic or patients with mild covid-19 symptoms confirmed sars-cov-2 infection within 5 days prior to randomization
June 21, 2022, 7:30 p.m.	usa	inclusion criteria: aged over 16 years old with all genders sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) patient or immediate adult family member agrees to participate in this study and signs an informed consent form with mild covid-19 symptoms confirmed sars-cov-2 infection within 5 days prior to randomization	inclusion criteria: aged over 16 years old with all genders sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) patient or immediate adult family member agrees to participate in this study and signs an informed consent form with mild covid-19 symptoms confirmed sars-cov-2 infection within 5 days prior to randomization
June 9, 2022, 4 p.m.	usa	None	None
June 3, 2022, 2 p.m.	usa	inclusion criteria: aged over 16 years old with all genders sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) patient or immediate adult family member agrees to participate in this study and signs an informed consent form with mild covid-19 symptoms confirmed sars-cov-2 infection within 5 days prior to randomization	inclusion criteria: aged over 16 years old with all genders sars-cov-2 positive（laboratory-confirmed reverse transcription polymerase chain reaction (rt pcr) test) patient or immediate adult family member agrees to participate in this study and signs an informed consent form with mild covid-19 symptoms confirmed sars-cov-2 infection within 5 days prior to randomization